Industry round-up: GE Healthcare, Medrad, NAI, Primera, SmartPill, Tyko
GE Healthcare has achieved International Organization for Standardization (ISO) 9001:2000 recertification of its Biomedical Clinical Services Division. ISO certification is a voluntary certification that examines a company’s procedures to ensure the production of quality products and services. Today, ISO is a network of 157 countries working together to establish universal standards for businesses.
As part of the ISO recertification process, the division underwent external audits to prove that quality processes are consistently maintained in all 567 biomedical repair facilities. The certification also provides Biomedical Clinical Services with a standard approach to applying a quality management system.

Medrad reported sales revenues of $478 million in 2006, an increase of 16 percent over the previous year. The medical device company has achieved a 15 percent compounded annual growth in sales for over 10 years. Last year saw the company’s introduction of its Certo MR Wireless Network, which allows the company’s wireless-enabled equipment to travel with the patient from the prep room to the scanner room and then to the recovery area, while maintaining full communication with the remote display on the network. Also, the company’s Stellant and Vistron CT Injection Systems both reached the milestone of 5,000 systems installed worldwide last year.

Primera Technology and NAI Tech Products introduced a new medical solution that writes DICOM images from any medical imaging modality to CD or DVD automatically. NAI’s MDR Express Software – when integrated in Primera’s Disc Publisher XRP (Server Package) – offers an automatic disc production from every modality just by clicking a button.

SmartPill’s GI Monitoring System is now being used by Dr. Arun Ohri, a gastroenterologist with Resurrection Medical Center in Chicago. Ohri is the first doctor in the region to use the new technology in a physician practice. The SmartPill GI Monitoring System aids in the diagnosis of gastrointestinal (GI) motility disorders, including those suffering from symptoms of slow gastric emptying, a condition known as gastroparesis. Symptoms of gastroparesis include heartburn, nausea, vomiting of undigested food, abdominal bloating, erratic blood glucose levels and spasms of the stomach wall.

Tyco Healthcare appointed Timothy R. Wright as president of its $1.2 billion pharmaceutical products business and its $900 million Imaging Solutions business, which provides a full line of radiopharmaceuticals and contrast media delivery systems for the early diagnosis and treatment of disease.
A former interim CEO and member of the board of directors at AAIPharma, Wright brings more than 20 years of pharmaceutical industry experience to his new role as leader of overall management and strategic direction for two of Tyco Healthcare’s most important business segments.